# To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.

> **NCT06870422** · PHASE1 · COMPLETED · sponsor: **Teikoku Seiyaku Co., Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Esflurbiprofen Topical System

## Key facts

- **NCT ID:** NCT06870422
- **Lead sponsor:** Teikoku Seiyaku Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-28
- **Primary completion:** 2025-04-03
- **Final completion:** 2025-04-14
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06870422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06870422, "To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06870422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*